Non-alcoholic fatty liver disease
With the worldwide spread of sedentary lifestyle and diet westernization, the prevalence of non-alcoholic fatty liver disease (NAFLD) has increased in many countries among children and the elderly alike[1,2]. Approximately 25% of adults in the United States have fatty liver in the absence of excessive ethanol consumption. In Japan, roughly a third of individuals were found to have NAFLD in annual health checkups, translating to an estimated 20 million NAFLD patients. In China, fatty liver disease is increasing at a rate of 0.594% per year and is expected to afflict 20% of Chinese by 2020. NAFLD is becoming the most common liver disease worldwide.
NAFLD is frequently associated with increased visceral adiposity (obesity) and ensuing metabolic abnormalities, including insulin resistance, diabetes, hypertension, dyslipidemia, atherosclerosis, and systemic micro-inflammation. A recent meta-analysis involving over 8.5 million individuals from 22 countries showed that more than 80% of NASH patients were overweight or obese, 72% had dyslipidemia, and 44% had type 2 diabetes mellitus. Therefore, NAFLD can also be regarded as a hepatic manifestation of metabolic syndrome. Although it remains controversial whether NAFLD is a cause or a result of glucose intolerance and insulin resistance, a prospective study has demonstrated higher risks of diabetes and cardiovascular events in non-diabetic NAFLD patients than non-NAFLD ones. Therefore, NAFLD is a detrimental condition necessitating appropriate interventions.
Mild to moderate fatty liver multidisciplinary rehabilitation combination (1-month trial portion)
Significant progress: about 2-3 months
Professional rehabilitation combination:
• Please follow the doctor's advice for drugs and other medical plans
• Please follow the dietitian's guidelines for diet and nutrition
• For sports and or psychological counseling, please refer to the suggestions of experts
• To avoid misdiagnosis and missed diagnosis, please upload the professional diagnosis report of the hospital in the latest month
Not suitable for use:
- Hepatic fibrosis and sclerosis
- Alcoholic fatty liver
- Allergic to the ingredients of the combination
- Gastric ulcer
- Don't eat too full, mainly 80% full belly
- Try to reduce the amount of carbohydrate food
- High fat and cholesterol foods must be avoided and eaten less
- Drink plenty of boiled water, 2 liters a day
- Eat more dietary fiber food
- Get rid of the night snack habit
- It is not suitable to supplement minerals such as calcium and iron
- Go to bed early and get up early. Don't stay up late
- No less than 10000 steps of medium speed walking every day
- Try to eat less fried and roasted food
- Do not eat high iron foods such as animal liver and blood
• It is a nutritional supplement and cannot replace drugs.
• Pregnant or lactating women, infants and young children, please do not eat this product.
• If you do not know the cause of the problem or the problem continues, please consult your doctor as soon as possible.
- An update on drug development for the treatment of nonalcoholic fatty liver disease – from ongoing clinical trials to future therapy. Monika Rau &Andreas Geier. https://doi.org/10.1080/17512433.2021.1884068
- Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E. Current status, problems, and perspectives of non-alcoholic fatty liver disease research. World J Gastroenterol. 2019;25(2):163-177. doi:10.3748/wjg.v25.i2.163